To this end, two MGMT-negative patient-derived glioma initiating cell lines, #1095 and its radiation-resistant counterpart #1095_IR (Fig. S5A–D), were exposed to MS-275, TMZ and TMZ/MS-275 and the RAD18 protein expression was determined (Fig. 6A). The gene discussed is MGMT; the disease is central nervous system cancer.